Enanta Pharmaceuticals Inc. buy Rodman & Renshaw
Start price
26.03.26
/
50%
€10.60
Target price
26.03.27
€17.30
Performance (%)
4.72%
Price
08:10
?
Summary
This prediction is currently active. The BUY prediction by Rodman___Renshaw shows slight gains of 4.72%. This prediction currently runs until 26.03.27. The prediction end date can be changed by Rodman___Renshaw at any time. Rodman___Renshaw has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Enanta Pharmaceuticals Inc. | -6.723% | -6.723% |
| iShares Core DAX® | 0.855% | 0.389% |
| iShares Nasdaq 100 | -0.989% | -4.400% |
| iShares Nikkei 225® | -1.781% | -11.216% |
| iShares S&P 500 | 0.057% | 0.778% |
Comments by Rodman___Renshaw for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Enanta Pharmaceuticals (ENTA) is now covered by Rodman & Renshaw. They set a "buy" rating and a $20.00 price target on the stock.
Ratings data for ENTA provided by MarketBeat